Rimonabant Health Web Site Launches New Forum

A new forum on the Rimonabant Health web site allows consumers to interact and discuss their experiences with the Rimonabant series of drugs.

Scottsdale, AZ (PRWEB) July 7, 2007 -- In a refreshing move to encourage open discussion about its medication, the Rimonabant Health web site (available online at http://www.rimonabant-health.com) has launched a new online public forum.

"It is often extremely useful for patients to talk to and learn from each other, whether it is to share experiences or to lend support," says Scott Smith of Rimonabant Health. "The new Forums section on the Rimonabant Health web site lends itself to exactly that kind of healthy interaction."

Rimonabant is the active chemical in the Acomplia range of medication. Acomplia battles obesity by blocking specific receptors in the brain and fat tissues, and it is an effective adjunct to diet and exercise. Acomplia is already available in several countries outside the United States.

Another prospective product in the war against obesity, Taranabant, is in trial, with the intention of developing a drug that is fewer side effects that any other obesity drug on the market.

The Rimonabant Health forums allow users to talk about experiences with the Acomplia range of medication, as well as to ask questions, share answers, and discuss possible side effects.

"Obesity problems in developed nations continue to grow at a frightening pace, and we want to prove that these problems can fought," says Smith. "Our forums take the battle to another level, allowing people to band together in the war against obesity."

###